Glutamine synthetase functions as a negative growth regulator in glioma
Glutamine synthetase functions as a negative growth regulator in glioma
复制标题
DOI:
10.1007/s11060-013-1168-5
复制
发表时间:
2013-06
影响因子:
3.9
通讯作者:
Ying Yin;Weifeng Sun;J. Xiang;Lingxiao Deng;Bin Zhang;P. Xie;W. Qiao;Jian Zou;Chunxing Liu
中科院分区:
文献类型:
--
作者:
Ying Yin;Weifeng Sun;J. Xiang;Lingxiao Deng;Bin Zhang;P. Xie;W. Qiao;Jian Zou;Chunxing Liu
Our recent study demonstrated that glutamine synthetase (GS) may not only serve as a glutamate-converting enzyme in glial cells, but may also function as a regulator of astrocyte migration after injury. In this report, we showed that GS expression increased in cultured rat C6 glioma cells that underwent long-term serially propagation. The stable overexpression of GS in C6 glioma cells resulted in growth arrest and motility suppression; however the stable knockdown of GS resulted in motility enhancement. In correlation with cell aggregation,N-cadherin levels increased at sites of cell–cell contact in C6 cells overexpressing GS, and decreased in C6 cells with stable GS knockdown; totalN-cadherin expression levels remained unchanged in these cells. In addition, levels of p21, a potent cyclin-dependent kinase inhibitor, increased, while cyclin D1 levels decreased in C6 cells overexpressing GS. Our additional studies showed thatN-cadherin-mediated cell–cell contacts were implicated in GS-induced cell growth arrest and impairment of cell migration, as evidenced by the inhibition of GS on cell growth and motility by the neutralizing anti-N-cadherin monoclonal antibody (GC-4 mAb). Collectively, these observations suggest a novel mechanism of growth regulation by GS that involvesN-cadherin mediated cell–cell contact.